Blocking Autophagy Key to Treating Resistant Tumors?
VANCOUVER, British Columbia – The industry is redoubling its efforts to discover specific inhibitors of autophagy – the route by which cells degrade and recycle proteins – as evidence mounts from preclinical research and academic trials of the therapeutic potential of blocking that process.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter